Novel approach of desensitization in allergic reaction to Olaparib.

Abstract excerpt

INTRODUCTION: PARP (Poly ADP Ribose Polymerase) inhibitors are an effective maintenance therapy for various entities, such as BRCA (breast cancer gene) mutated or HRD (homologous recombination deficiency) positive primary platin-sensitive advanced ovarian cancer after platin induction therapy and in relapse after responding to carboplatin reinduction. Other entities are metastatic BRCA mutated pancreas, prostate...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Hypersensitivity
• Share to Mutation